BlackRock »

Lyra Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 1.7k 6.53
2025-06-30 $15k 1.7k 8.96

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Netflix (NFLX)

View all positions for BlackRock

Top funds holding Lyra Therapeutics

Perceptive Advisors
Sabby Management
Vanguard Group
Ikarian Capital
Citadel Advisors
Geode Capital Management
UBS Group
Morgan Stanley
BlackRock
Royal Bank of Canada
Tower Research Capital
FMR
Signature Resources Capital Management
EverSource Wealth Advisors
Jones Financial Companies, L.L

View all funds holding Lyra Therapeutics